Back to Feed
ClinicalTrials.gov|Clinical Trial

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

Noah Tech, Corp.

Abstract

This study aims to evaluate the efficacy of community-based early detection and targeted interventions, including stem cell therapy and wearable non-invasive brain-computer interface (BCI) devices, for Mild Cognitive Impairment (MCI) in adults aged 55 years and older residing in U.S. urban and suburban communities. Primary objectives include assessing improvements in MCI detection rates, cognitive outcomes, and progression delay compared to standard care. Phase: EARLY_PHASE1 Status: NOT_YET_RECRUITING Conditions: Mild Cognitive Impairment (MCI); Early Stages of Cognitive Decline; Alzheimer's Disease Dementia; Alzheimer's Disease Diagnosis; Alzheimer's Disease and Related Dementias; Parkinson's Disease; Parkinson's Disease (PD); Parkinson's Disease With Wearing-off Motor Fluctuations; Dementia (Diagnosis); Dementia MCI (Mild Cognitive Impairment) Interventions: Structured wellness care; Wearable brain-computer interface devices; Stem Cell Therapy - Experimental; Control - Placebo Comparator

Keywords

Mild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease DementiaAlzheimer's Disease DiagnosisAlzheimer's Disease and Related DementiasParkinson's DiseaseParkinson's Disease (PD)Parkinson's Disease With Wearing-off Motor FluctuationsDementia (Diagnosis)Dementia MCI (Mild Cognitive Impairment)
Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. | StemCell Pulse | StemCell Pulse